Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

ADC Therapeutics (ADCT) Depreciation and Depletion (2020 - 2023)

Historic Depreciation and Depletion for ADC Therapeutics (ADCT) over the last 5 years, with Q4 2023 value amounting to $335000.0.

  • ADC Therapeutics' Depreciation and Depletion fell 6837.33% to $335000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $1.2 million, marking a year-over-year increase of 1198.11%. This contributed to the annual value of $1.3 million for FY2024, which is 1238.42% up from last year.
  • According to the latest figures from Q4 2023, ADC Therapeutics' Depreciation and Depletion is $335000.0, which was down 6837.33% from $316000.0 recorded in Q3 2023.
  • In the past 5 years, ADC Therapeutics' Depreciation and Depletion registered a high of $1.1 million during Q4 2022, and its lowest value of $88.0 during Q3 2019.
  • Over the past 5 years, ADC Therapeutics' median Depreciation and Depletion value was $261.0 (recorded in 2022), while the average stood at $159746.9.
  • Per our database at Business Quant, ADC Therapeutics' Depreciation and Depletion tumbled by 9988.24% in 2021 and then surged by 31235781.71% in 2022.
  • ADC Therapeutics' Depreciation and Depletion (Quarter) stood at $195.0 in 2019, then skyrocketed by 75797.44% to $148000.0 in 2020, then crashed by 99.77% to $339.0 in 2021, then surged by 312357.82% to $1.1 million in 2022, then tumbled by 68.37% to $335000.0 in 2023.
  • Its Depreciation and Depletion stands at $335000.0 for Q4 2023, versus $316000.0 for Q3 2023 and $273000.0 for Q2 2023.